Ballante F - Search Results

1

Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines.

Nencetti S, Cuffaro D, Nuti E, Ciccone L, Rossello A, Fabbi M, Ballante F, Ortore G, Carbotti G, Campelli F, Banti I, Gangemi R, Marshall GR, Orlandini E. Nencetti S, et al. Among authors: ballante f. J Enzyme Inhib Med Chem. 2021 Dec;36(1):34-47. doi: 10.1080/14756366.2020.1835883. J Enzyme Inhib Med Chem. 2021. PMID: 33100043 Free PMC article.

2

Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.

Reddy DN, Ballante F, Chuang T, Pirolli A, Marrocco B, Marshall GR. Reddy DN, et al. Among authors: ballante f. J Med Chem. 2016 Feb 25;59(4):1613-33. doi: 10.1021/acs.jmedchem.5b01632. Epub 2016 Jan 7. J Med Chem. 2016. PMID: 26681404

3

Design and synthesis of benzodiazepine analogs as isoform-selective human lysine deacetylase inhibitors.

Reddy DR, Ballante F, Zhou NJ, Marshall GR. Reddy DR, et al. Among authors: ballante f. Eur J Med Chem. 2017 Feb 15;127:531-553. doi: 10.1016/j.ejmech.2016.12.032. Epub 2016 Dec 18. Eur J Med Chem. 2017. PMID: 28109947

4

Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy.

Ballante F, Reddy DR, Zhou NJ, Marshall GR. Ballante F, et al. Bioorg Med Chem. 2017 Apr 1;25(7):2105-2132. doi: 10.1016/j.bmc.2017.02.020. Epub 2017 Feb 13. Bioorg Med Chem. 2017. PMID: 28259528

5

Histone deacetylase inhibitors: structure-based modeling and isoform-selectivity prediction.

Silvestri L, Ballante F, Mai A, Marshall GR, Ragno R. Silvestri L, et al. Among authors: ballante f. J Chem Inf Model. 2012 Aug 27;52(8):2215-35. doi: 10.1021/ci300160y. Epub 2012 Jul 19. J Chem Inf Model. 2012. PMID: 22762501

6

An Automated Strategy for Binding-Pose Selection and Docking Assessment in Structure-Based Drug Design.

Ballante F, Marshall GR. Ballante F, et al. J Chem Inf Model. 2016 Jan 25;56(1):54-72. doi: 10.1021/acs.jcim.5b00603. Epub 2016 Jan 6. J Chem Inf Model. 2016. PMID: 26682916

7

Limiting Assumptions in the Design of Peptidomimetics.

Marshall GR, Ballante F. Marshall GR, et al. Among authors: ballante f. Drug Dev Res. 2017 Sep;78(6):245-267. doi: 10.1002/ddr.21406. Epub 2017 Sep 6. Drug Dev Res. 2017. PMID: 28875546 Review.

8

Comprehensive model of wild-type and mutant HIV-1 reverse transciptases.

Ballante F, Musmuca I, Marshall GR, Ragno R. Ballante F, et al. J Comput Aided Mol Des. 2012 Aug;26(8):907-19. doi: 10.1007/s10822-012-9586-6. Epub 2012 Jul 26. J Comput Aided Mol Des. 2012. PMID: 22833004

9

Exploring the role of 2-chloro-6-fluoro substitution in 2-alkylthio-6-benzyl-5-alkylpyrimidin-4(3H)-ones: effects in HIV-1-infected cells and in HIV-1 reverse transcriptase enzymes.

Rotili D, Tarantino D, Nawrozkij MB, Babushkin AS, Botta G, Marrocco B, Cirilli R, Menta S, Badia R, Crespan E, Ballante F, Ragno R, Esté JA, Maga G, Mai A. Rotili D, et al. Among authors: ballante f. J Med Chem. 2014 Jun 26;57(12):5212-25. doi: 10.1021/jm500284x. Epub 2014 Jun 16. J Med Chem. 2014. PMID: 24933420

10

2-(Alkyl/aryl)amino-6-benzylpyrimidin-4(3H)-ones as inhibitors of wild-type and mutant HIV-1: enantioselectivity studies.

Rotili D, Samuele A, Tarantino D, Ragno R, Musmuca I, Ballante F, Botta G, Morera L, Pierini M, Cirilli R, Nawrozkij MB, Gonzalez E, Clotet B, Artico M, Esté JA, Maga G, Mai A. Rotili D, et al. Among authors: ballante f. J Med Chem. 2012 Apr 12;55(7):3558-62. doi: 10.1021/jm201308v. Epub 2012 Mar 26. J Med Chem. 2012. PMID: 22428851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page